Ganga Pharmaceuticals Limited reported audited standalone earnings results for the half year and full year ended March 31, 2016. For the half year, the company's total income from operations was INR 15.478 million compared to INR 14.327 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1.723 million compared to INR 1.886 million a year ago. Profit from ordinary activities before tax was INR 0.072 million compared to INR 0.270 million a year ago. Net profit for the period was INR 0.020 million compared to INR 0.187 million a year ago. Basic and diluted earnings per share before and after extraordinary items was INR 0.01 compared to INR 0.08 a year ago. Net sales/income from operations were INR 14.155 million compared to the INR 13.465 million a year ago. For the year, the company's total income from operations was INR 28.365 million compared to INR 28.671 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 3.960 million compared to INR 3.796 million a year ago. Profit from ordinary activities before tax was INR 0.701 million compared to INR 0.490 million a year ago. Net profit for the period was INR 0.484 million compared to INR 0.335 million a year ago. Basic and diluted earnings per share before and after extraordinary items was INR 0.16 compared to INR 0.14 a year ago. Net sales/income from operations were INR 27.007 million compared to the INR 26.947 million for the previous year.